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Abstract The aim of this study was to examine the
occurrence of end-stage renal disease (ESRD) in Slovak
children, to compare it with earlier Slovak data and with data
from other European countries, and to explore etiology. Over
the years 2003–2009, data on the incidence and prevalence
of all cases of ESRD in children from all four Slovak tertiary
pediatric centers were collected. The data were compared
with two earlier Slovak studies and with European data from
the European Society of Paediatric Nephrology. The median
annual incidence rate of ESRD in Slovak children under
15 years of age was 6.6 per million age-related population
(pmarp). The prevalence rate on 31 December 2009 was
24.1 pmarp. Compared with the last study (18.6 pmarp), the
differences were not statistically significant. The comparison
with neighboring countries and with the European average
shows no significant difference in incidence, while preva-
lence is significantly lower compared to neighboring Austria
and some other (mostly western) European countries as well
as the European average. In conclusion, during the past
decade, the incidence and prevalence rates of ESRD in
Slovak children have remained stable. Compared to the
European average, the prevalence in Slovak children is
significantly lower.
Keywords End-stage renal disease . Incidence .
Prevalence . Etiology . Renal replacement therapy
Introduction
The pediatric population suffering from end-stage renal
disease (ESRD) in Europe is growing. Children with
formerly lethal diseases nowadays survive until adulthood
and beyond [11]. The reported number of children on renal
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replacement therapy (RRT) has almost tripled during a
relatively short period of 15 years [8, 13, 14].
Nevertheless, reliable epidemiological information on
ESRD and RRT in European children is not easy to obtain.
One source of information is the annual reports of the
European Renal Association–European Dialysis Transplan-
tation Association (ERA-EDTA), but these reports are
somewhat limited since data are often lacking, especially
from Central and Eastern European countries. This is
probably a consequence of the absence of official national
or regional registries in most of these countries, including
Slovakia [15]. In 2007, the European Society of Paediatric
Nephrology (ESPN) began collecting data on pediatric
renal replacement therapy (RRT) patients exclusively on the
basis of national or large regional registries in an attempt to
solve the problem of insufficient information.
In Slovakia, only two pediatric epidemiologic studies on
this topic have been published so far. The first such study
was by Zvara et al. in the years 1975–1977 and included
children under the age of 15 years with chronic kidney
disease (CKD) [17]. As a result of unavailability of dialysis
and transplantation, the prevalence of RRT at that time was
only 1.5 per million age-related population (pmarp) under
15 years of age (0.4 per million total population—pmtp).
The next study on Slovak children was done in the year
2002 by Podracka et al., but this study was done on CKD
children in a different age category (under 18 years of age)
revealing a prevalence rate of 29.3 pmarp for this age group
(7.4 children pmtp) [10].
Up to now, a national register with the potential of
monitoring health care of pediatric end-stage renal disease
patients has not been established in Slovakia. Therefore, the
main aims of the present study are:
1. To evaluate the actual incidence and prevalence rates of
ESRD and RRT in Slovak children;
2. To compare the results regarding 2003–2009 with those
from earlier epidemiological surveys carried out in
Slovakia;
3. To compare the incidence and prevalence rates of
ESRD and RRT in Slovak children with those of
children from other European countries;
4. To compare the etiology, i.e., primary renal diseases and
treatment modes, with earlier studies on Slovak children
and on children from other European countries.
Materials and methods
Patients
According to a new ERA-EDTA policy, this epidemiologic
study evaluated data from all four tertiary centers for
pediatric nephrology in Slovakia (Bratislava, Košice,
Banská Bystrica, and Martin) treating all pediatric RRT
patients [2]. The total sample consisted of 83 patients below
the age of 19 years (32 girls, 51 boys) treated for ESRD in
Slovakia in the period 1 January 2003 to 31 December
2009. Population data were obtained from the Statistical
Office of the Slovak Republic.
Procedure and measures
Data were collected using questionnaires sent to the heads
of all four pediatric dialysis and transplantation centers in
Slovakia. For each patient, age, gender, and clinical
variables were retrieved. Clinical variables were derived
from the medical files by one of the authors (GK) regarding
the primary renal disease, the date and mode of the first
RRT (peritoneal dialysis (PD), hemodialysis (HD), or
preemptive transplantation), and changes in treatment
including date and type of each transplantation (preemptive
or non-preemptive, from a living or deceased donor). The
primary renal diseases were recorded as diagnosed by all
four centers in Slovakia and divided into the categories
according to ERA-EDTA [4].
For comparison of incidence and prevalence rates of RRT
with other European countries on the basis of ESPN datasets,
the upper age limit was set to 14 years. Patients were divided
into 5-year categories (0–4, 5–9, 10–14). For complete
analysis of the Slovak situation, we added an extra category
of 15–18-year-old children, as these patients are considered
pediatric (under 19 years old) in Slovakia and other countries.
Incidence and prevalence rates were calculated as pmarp
and pmtp in the different age categories (0–4, 5–9, 10–14,
15–18). Prevalence rates were expressed as the number of
ESRD patients alive and on RRT on 31st December of each
year. Data on RRT from other European countries were
derived from ESPN/ERA-EDTA annual reports [5, 6].
Statistical analyses
Descriptive data regarding incidence and prevalence rates of
RRT from 2003 to 2009 were presented. Poisson regression
was used to find significant differences between the last
study from 2002 and actual data from 2009. Differences
between Slovakia and neighboring countries were compared
over the years 2007–2008 using test of proportions. The
differences were considered statistically significant at a p
level of 0.05. SAS 9.2 was used for the statistical analyses.
Results
Between 1 January 2003 and 31 December 2009, 52 new
patients reached ESRD before the age of 19 years and
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initiated RRT in Slovakia. The median age of the patients at
the start of RRT was 12 years, and the range was 0–
18 years. The male/female ratio of the patients was 1.58.
Age distribution and incidence and prevalence rates
The largest portion of the patients (n=20) was aged 10 to
14 years when they initiated RRT; 18 patients were 15 to
18 years old; and six were younger than age of 5 years at
the time of RRT initiation (Table 1). The median annual
incidence rate of RRT (during the study period 2003–2009)
was 6.6 pmarp under age 15 years (1.5 pmtp). The current
prevalence rate of RRT in Slovak children under 15 years
old (measured on 31 December 2009) was found to be 24.1
pmarp (3.7 pmtp). Table 1 shows the incidence and
prevalence rates in detail during the whole study period.
The average mortality of patients under the age of 15 years
on RRT during the whole period was 1.3%.
Comparison with earlier Slovak epidemiological surveys
In the first Slovak study, done in 1977 by Zvara et al., only
the prevalence rate under the age of 15 years was explicitly
described (1.5 pmarp, 0.4 pmtp) [17]. The study performed
in 2002 presented data regarding children under the age of
18 years [10]. To allow for a direct comparison, we
recalculated the rates for children under the age of 15 years.
The incidence rate was then 4.1 pmarp under 15 years (0.7
pmtp), and the prevalence rate was 18.6 pmarp under
15 years (3.2 pmtp). A slightly positive trend both for
incidence and prevalence is currently present, although the
differences between 2002 and 2009 are not statistically
significant.
Slovakia compared to other European countries
The comparison of incidence and prevalence of RRT among
Slovak children with children from other European
countries using data published by ESPN in 2009–2010 for
the years 2007–2008 is presented in Table 2. The
comparison with Slovakia’s neighboring countries and with
the European average shows no significant difference in
incidence. The Slovak prevalence does not differ than that
of most of its neighbors, but it is significantly lower
compared with neighboring Austria. The same holds true in
the comparison of Slovak prevalence with some other
Table 1 Incidence and prevalence rates of RRT in Slovak children according to age and gender over the years 2003–2009
Total Gender Age groups
0–18 Girls Boys 0–4 5–9 10–14 15–18
n [pmarp] n [pmarp] n [pmarp] n [pmarp] n [pmarp] n [pmarp] n [pmarp]
Incidence
2002 n.a. n.a. n.a. 0 [0.0] 1 [3.2] 3 [7.7] n.a.
2003 6 [4.6] 2 [3.2] 4 [6.1] 0 [0.0] 1 [3.3] 2 [5.2] 3 [8.9]
2004 9 [7.2] 4 [6.6] 5 [8.2] 2 [7.7] 1 [3.4] 4 [10.9] 2 [6.1]
2005 8 [6.6] 2 [3.7] 6 [9.6] 2 [7.7] 1 [3.5] 5 [14.3] 0 [0.0]
2006 6 [5.1] 5 [9.3] 1 [1.6] 0 [0.0] 2 [7.8] 2 [6.0] 2 [6.3]
2007 9 [8.3] 4 [7.6] 5 [9.0] 1 [3.8] 0 [0.0] 3 [9.5] 5 [16.2]
2008 4 [3.8] 3 [5.8] 1 [1.8] 1 [3.7] 1 [3.8] 1 [3.3] 1 [3.3]
2009 10 [8.9] 1 [1.8] 9 [15.7] 0 [0.0] 2 [7.7] 3 [10.3] 5 [17.3]
Median 2003–2009 8 [6.6] 3 [5.8] 5 [8.2] 1 [3.7] 1 [3.5] 3 [9.5] 2 [6.3]
Prevalence
2002 n.a. n.a. n.a. 1 [3.8] 6 [19.1] 11 [28.4] n.a.
2003 35 [27.3] 13 [20.7] 22 [35.1] 1 [3.8] 3 [10.0] 9 [23.6] 22 [64.9]
2004 41 [32.8] 14 [23.0] 27 [44.3] 1 [3.9] 6 [20.6] 9 [24.5] 25 [75.9]
2005 43 [35.3] 14 [23.6] 29 [48.8] 2 [7.7] 6 [21.1] 12 [34.3] 23 [71.4]
2006 42 [35.4] 18 [31.1] 24 [41.4] 1 [3.8] 8 [29.1] 14 [42.1] 19 [59.9]
2007 44 [37.9] 18 [31.8] 26 [46.0] 2 [7.5] 6 [22.5] 15 [47.3] 21 [68.0]
2008 39 [34.3] 20 [36.0] 19 [34.2] 3 [11.0] 5 [19.1] 12 [39.8] 19 [62.9]
2009 40 [35.7] 18 [32.9] 22 [40.3] 2 [7.1] 4 [15.4] 14 [48.1] 20 [69.1]
Median 2003–2009 41 [35.3] 18 [31.1] 24 [41.4] 2 [7.1] 6 [20.6] 12 [39.8] 21 [68.0]
n.a. not available
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(mostly western) European countries as well as the
European average.
Etiology
The distribution of primary diseases leading to ESRD in
Slovak children between 1 January 2003 and 31 December
2009 is shown in Table 3. Congenital anomalies of the
kidneys and urinary tract (CAKUT) with kidney (hypo)
dysplasia comprised the major cause. Cystic diseases were
the next in importance. The predominance of congenital
and hereditary disorders as a leading cause of ESRD
compared with acquired nephropathies was evident.
The distribution of primary diseases could not be
compared directly with previous studies because the
etiology in those studies was only described in regard to
all CKD patients but not regarding those in ESRD
separately. Regarding all CKD patients, the reported
distribution of primary diseases was: CAKUT, 52.4%;
hereditary disorders, 14.3%; glomerular diseases, 28.6%;
and interstitial nephritides, 4.8% in 1977; and CAKUT,
37.5%, hereditary disorders, 26.5%, glomerular diseases,
11.5%; and interstitial nephritides, 18.5% in 2002.
Treatment mode
During the study period, 27 patients (51.9%) (younger than
19 years old) started RRT on PD and 24 patients (46.2%)
started their RRT on HD. Only one patient (1.9%) was
transplanted preemptively. Out of all the first transplanta-
tions, 22.0% were from living-related donors. In previous
Slovak surveys, initial treatment modalities were not
described [10, 17]. Compared to published data on the
overall proportion of preemptive transplantations in Europe
(15.1%), the proportion of preemptive transplantations in
Slovak children is significantly lower. Regarding the
prevalent treatment modalities measured on 31 December
2008, the proportion of HD patients (n=8; 20.5%) does not
significantly differ from the ERA-EDTA data (n=180;
13.1%), and the proportion of PD patients (n=12; 30.8% vs
n=100; 7.3%) is significantly higher and of transplanted
patients (n=19; 48.7% vs n=1097; 79.7%) significantly
lower compared to the ERA-EDTA 2010 annual report.
Discussion
This study presents an overview of the epidemiology and
etiology of ESRD and RRT in Slovak children, focusing on
changes observed in the period 2003–2009 compared to
historical data and data on the European perspective. The
median annual incidence rate of RRT in Slovak children
under age 15 years in this period was 6.6 pmarp. These
rates were somewhat higher than that in the preceding study
on Slovak children in 2002 [17], but without statistical
significance. Data on the incidence of RRT regarding the
first Slovak study from 1978 are not available, but it
seems likely that the number of patients initiating RRT
was lower as a consequence of the unavailability of
dialysis and transplantation in the past. Compared with
neighboring countries and with the European average, no
significant differences in incidence rates were found.
Explanations for these similarities are the similar demo-
graphic structure but also the seemingly comparable
availability of dialysis. An increase in the incidence
rates of RRT can thus be expected, as the European RRT
incidence is currently rising [6, 13, 15].
On the basis of the available prevalence data (1.5 pmarp
in 1977, 18.6 pmarp in 2002, 24.1 pmarp in 2009), it could
be assumed that the initially steep rise of RRT prevalence
rates stabilized a couple of years after introducing dialysis
and transplantation into the treatment regime of Slovak
children. Later variations could easily be due to fluctuation
by chance (18.6 pmarp in 2002, 27.0 pmarp in 2007, 24.1
pmarp in 2009). Regarding neighboring countries, preva-
lence rates were significantly higher in the neighboring
Austria but not in other neighboring countries. Moreover,
Table 3 Etiology of ESRD in new patients (cohort 2003–2009)
Etiology Total Gender
0–18 Girls Boys
n (%) n (%) n (%)
1. CAKUT 18 (34.6) 5 (23.9) 13 (42.0)
Renal hypo-/dysplasia 8 (15.3) 1 (4.8) 7 (22.7)
Vesico-ureteric reflux 3 (5.8) 2 (9.5) 1 (3.2)
Obstructive uropathy 7 (13.4) 2 (9.5) 5 (16.1)
Urethral valve 0 (0.0) 0 (0.0) 0 (0.0)
Obstruction without valve 6 (11.5) 1 (4.8) 5 (16.1)
Neurogenic bladder 1 (1.9) 1 (4.8) 0 (0.0)
2. Cystic disease 10 (19.2) 3 (14.4) 7 (22.7)
Polycystic kidney disease 4 (7.7) 1 (4.8) 3 (9.7)
Juvenile nephronophthisis 4 (7.7) 2 (9.5) 2 (6.5)
3. Hereditary nephropathy 5 (9.6) 3 (14.4) 2 (6.5)
Alport syndrome 2 (3.8) 2 (9.5) 0 (0.0)
4. Glomerulonephritis 8 (15.4) 5 (23.9) 3 (9.7)
FSGS 5 (9.6) 3 (14.3) 2 (6.5)
5. HUS 1 (1.9) 1 (4.8) 0 (0.0)
6. Vasculitis 2 (3.8) 0 (0.0) 2 (6.4)
7. Miscellaneous 6 (11.5) 3 (14.4) 3 (9.7)
8. Unknown 2 (3.8) 1 (4.8) 1 (3.2)
Total 52 (100.0) 21 (100.0) 31 (100.0)
ESRD end-stage renal disease, CAKUT congenital anomalies of
kidneys and urinary tract, HUS hemolytic-uremic syndrome, FSGS
focal segmental glomerulosclerosis
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the average European prevalence rate was higher. The
higher prevalence in Austria and in some other mostly
western European countries may be due to the combination
of improved medical care for patients in earlier stages of
CKD in combination with earlier treatment of ESRD,
especially in younger ages where a low weight can also
play a significant role for establishing dialysis [13, 15].
The predominance of congenital and hereditary reasons
as the main causes of ESRD in children has similarly been
found in a study on neighboring Poland [16] and in many
other previous studies on Europe [1, 3, 7] and other parts of
the world [9, 12]. A study of the British Association of
Paediatric Nephrology published in December 2009, the
most recent European study, reported a higher proportion of
CAKUT (50.0%) and congenital nephrosis (9.3%) [7]. A
Dutch study on the period 1987–2001 reported a
relatively very high proportion of urethral valves
(14.3%) as the reason for ESRD, which contrasts with
the Slovak results, in which there was zero contribution
of urethral valves among RRT patients. Environmental,
ethnic, and other differences might explain the different
occurrence of primary renal diseases in Europe compared
to our findings [15].
Strengths and limitations
An important strength of our study is that we obtained data
on the entire country using a rigorous data collection. A
limitation is the relatively small number of children, which
limits the potential for subgroup analyses.
Conclusion
A slightly positive trend both for incidence and prevalence
rates of pediatric RRT patients has been present in Slovakia
during the past decade, although no significant difference
compared to the last study (2002) was found. The comparison
with the neighboring countries and with the European
average shows no significant differences in incidence. The
prevalence does not significantly differ from that of most of
its neighbors but is significantly lower compared with
neighboring Austria and some other (mostly western)
European countries as well as the European average.
A central national registry for children on RRT should be
established, not only to facilitate epidemiological analyses
and longitudinal studies but also as a first step toward
monitoring and improving the quality of health care and
quality of life of Slovak children.
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